ARTICLE | Clinical News
Matritech regulatory update
November 14, 1994 8:00 AM UTC
Matritech Inc. (NMPS) The Cambridge, Mass., company filed for FDA approval of its Matritech NMP22 Test Kit for bladder cancer. The urine test uses NMPS's nuclear matrix protein (NMP) technology, whic...